By including a wide range of patients with varying demographic characteristics, disease stages, and risk profiles, the sensitivity, specificity, and predictive value of Gal-3 in detecting early-stage pancreatic tumours can be thoroughly assessed. The gene discussed is LGALS3; the disease is pancreatic neoplasm.